Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.840
-0.160 (-3.20%)
At close: Jun 17, 2025, 4:00 PM
4.790
-0.050 (-1.03%)
After-hours: Jun 17, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.97 billion as of June 17, 2025. Its market cap has decreased by -6.58% in one year.
Market Cap
1.97B
Enterprise Value
1.56B
1-Year Change
-6.58%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.97B, a decrease of -61.20%. That is a compound annual growth rate of -20.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 2.03B | -23.69% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.87B |
| Johnson & Johnson | 373.13B |
| Novo Nordisk | 355.28B |
| AbbVie | 336.92B |
| UnitedHealth Group | 277.30B |
| Abbott Laboratories | 234.72B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |